TSS
RCKTW icon

Two Sigma Securities’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Two Sigma Securities’s Portfolio RCKTW Stock Details RCKTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,500
Closed -$401 – 2110
2025
Q4 		$401 Buy
+16,500
New +$538 ﹤0.01% 1403

Other funds holding RCKTW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Securities's RCKTW Position: Q1 2026 in Review

Two Sigma Securities sold out of Rocket Pharmaceuticals Warrant (RCKTW) in Q1 2026, closing a stake of 16,500 shares — an estimated $401 sold.

Two Sigma Securities first reported a position in RCKTW in Q4 2025 and held it in 1 quarter. The position peaked at $401 in Q4 2025. 10 funds tracked by Wall St. Rank hold RCKTW as of Q1 2026.

  • Two Sigma Securities reported no remaining Rocket Pharmaceuticals Warrant position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 16,500 Rocket Pharmaceuticals Warrant shares in Q1 2026, an estimated $401.
  • Two Sigma Securities first reported a position in Rocket Pharmaceuticals Warrant in Q4 2025 and held it in 1 quarter.
  • Two Sigma Securities's Rocket Pharmaceuticals Warrant position peaked at $401 in Q4 2025.
  • 10 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.